NRBO - NeuroBo Pharmaceuticals GAAP EPS of -$1.32
2024-05-09 10:49:10 ET
More on NeuroBo Pharmaceuticals
- NeuroBo Phase 2a study for MASH drug to proceed as planned
- NeuroBo stock jumps 14% on weight-loss drug update
- Seeking Alpha’s Quant Rating on NeuroBo Pharmaceuticals
- Historical earnings data for NeuroBo Pharmaceuticals
- Financial information for NeuroBo Pharmaceuticals